Boule Diagnostics AB (publ) (BDABF)

3.5100 0.0000 (0.00%) At close: 11:59AM EDT

Boule Diagnostics AB (publ)

Domnarvsgatan 4
Spånga 163 53
Sweden
46 87 44 77 00
https://www.boule.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 228

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Torben Nielsen	CEO & Group President	N/A	N/A	N/A
Mr. Holger Lembrer M.Sc.	Chief Financial Officer	N/A	N/A	1984
Mr. Eduardo Pagani	Chief Operating Officer	N/A	N/A	N/A
Jorgen Jehander	Head of Development Department & Interim CTO	N/A	N/A	N/A
Ms. Simonetta Tumbiolo	Senior Vice President of Marketing	N/A	N/A	N/A
Ms. Aishat Bislieva	Senior Vice President of People & Culture	N/A	N/A	N/A
Mr. Kiarash Farr	Senior Vice President of Commercial Operations	N/A	N/A	N/A
David Metrena	Senior Vice President of Commercial Operations of US	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics companies. Boule Diagnostics AB (publ) was founded in 1956 and is headquartered in Spånga, Sweden.

Corporate Governance

Boule Diagnostics AB (publ)’s ISS Governance QualityScore as of April 29, 2024 is 7. The pillar scores are Audit: 7; Board: 9; Shareholder Rights: 1; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.